Results 131 to 140 of about 4,425,847 (185)

Multidisciplinary treatment incorporating autologous DC-CIK cell therapy induces long-term survival in advanced pancreatic cancer: a case report. [PDF]

Front Immunol
Chen S, Xie Y, Xu S, Su L, Xu Y, Liu S, Zheng Q, Liu Q, Sun Y.   +8 more
europepmc   +1 more source

CIK cells – current status, clinical perspectives and future prospects – the good news [PDF]

Expert Opinion on Biological Therapy, 2012
openaire   +2 more sources

A fish-specific E3 ubiquitin ligase NHRE3 suppresses antiviral immunity by degrading ISG15 via ubiquitination. [PDF]

PLoS Pathog
Xie J, Lei J, Zhu Q, Gui B, Li Y, Wang Y, Huang R.   +6 more
europepmc   +1 more source

Translational landscape of cytokine-induced killer cell therapy: an analysis based on the Informa database. [PDF]

J Immunother Cancer
Zhang Y, Sun H, Yuan Y, Liu D, Qiao J.
europepmc   +1 more source

LAK to CIK continuum in glioma immunotherapy: a systematic review of efficacy and safety outcomes. [PDF]

J Transl Med
Hamidi S, Morsali S, Ghannadikhosh P, Darvishi A, Nour MA, Zafarabadi S, Rahmani M, Doustvandi MA, Aghebati-Maleki L.   +8 more
europepmc   +1 more source

Cetuximab combination with cytokine induced killer cells effectively inhibit conjunctival squamous cell carcinoma in vitro. [PDF]

BMC Immunol
Aghaei H, Khakpour M, Dehghan S, Ghamari A, Shoae-Hassani A.   +4 more
europepmc   +1 more source

Clinical application of cytokine-induced killer cells in cancer immunotherapy. [PDF]

Cancer Cell Int
Ghorbani F, Abbaszadeh H, Yahyavi Y, Talebi M, Shamsasenajn K.   +4 more
europepmc   +1 more source

Comparative Evaluation of Kit-M (GM-CSF and PGE-1) and Kit-I (GM-CSF and Picibanil) for the Generation of DCs/DCleus and Their Impact on Subsequent Antileukemic Immune Cell Activation Ex Vivo. [PDF]

Cancers (Basel)
Deen D, Schutti O, Baudrexler T, Amberger DC, Plett C, Klauer L, Schmohl J, Bojko P, Kraemer D, Rank A, Schmetzer H.   +10 more
europepmc   +1 more source